Group 1 - The company, Zhendemedical, reported a revenue of approximately 2.1 billion yuan for the first half of 2025, representing a year-on-year increase of 2.83% [1] - The net profit attributable to shareholders of the listed company was approximately 128 million yuan, showing a year-on-year decrease of 20.7% [1] - The basic earnings per share were 0.48 yuan, which is a year-on-year decrease of 20% [1]

Group 1 - The core transaction of Zhend Medical on August 27 involved a total volume of 100,000 shares and a transaction amount of 2.32 million yuan [1][2] - The average transaction price was 23.20 yuan, which reflects no discount compared to the closing price of the day [1][2] - The transaction was executed through the brokerage firms Guotai Junan Securities Co., Ltd. and Dongfang Securities Co., Ltd. [2]

Core Viewpoint - Zhendemedical (603301.SH) reported a revenue of 2.1 billion yuan for the first half of 2025, reflecting a year-on-year growth of 2.83% [1] - The net profit attributable to shareholders of the listed company was 128 million yuan, showing a year-on-year decline of 20.70% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 118 million yuan, down 26.97% year-on-year [1] - The basic earnings per share stood at 0.48 yuan [1]

Core Viewpoint - ZhenDe Medical Products Co., Ltd. reported a slight increase in revenue for the first half of 2025, but a significant decline in net profit due to various operational challenges and market conditions [1][2]. Company Overview and Financial Indicators - ZhenDe Medical was established in 1994 and integrates R&D, production, and sales in the medical and health industry [3]. - The company achieved operating revenue of CNY 2.1 billion in the first half of 2025, a 2.83% increase from the previous year [2]. - The total profit for the period was CNY 157 million, down 20.61% year-on-year, with net profit attributable to shareholders at CNY 127.76 million, a decrease of 20.70% [2][3]. - The company’s net assets were CNY 5.63 billion, showing a slight decrease of 0.20% compared to the end of the previous year [2]. Business Operations - The company has a comprehensive product line covering various medical fields, including modern wound care, surgical infection control, and personal health care products [3][4]. - ZhenDe Medical has established a global marketing network, with products sold in over 70 countries and regions [3]. - The company’s domestic sales strategy includes both direct sales and partnerships with distributors, covering nearly 9,200 hospitals in China [3][4]. Industry Context - The global medical device market is projected to grow steadily, driven by an aging population and increasing health awareness, with an estimated market size of USD 603.1 billion in 2024 [11][12]. - The Chinese medical device market is expected to reach CNY 106.38 billion in 2024, reflecting a growth rate of 3% [11][12]. - The low-value medical consumables market in China is anticipated to grow to CNY 134.4 billion in 2024, with a year-on-year increase of 5% [11][12]. - The industry is experiencing a shift towards higher concentration, with larger companies gaining market share due to their comprehensive R&D capabilities [11][12].

前 10 名股东持股情况 | 振德医疗用品股份有限公司2025 | 年半年度报告摘要 | | | | | | --- | --- | --- | --- | --- | --- | | 公司代码：603301 | 公司简称：振德医疗 | | | | | | 振德医疗用品股份有限公司 | | | | | | | 振德医疗用品股份有限公司2025 | 年半年度报告摘要 | | | | | | 第一节 重要提示 | | | | | | | 展规划，投资者应当到 www.sse.com.cn | 网站仔细阅读半年度报告全文。 | | | | | | 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 | | | | | | | 公司2025年中期不进行利润分配或资本公积金转增股本。 | | | | | | | 第二节 公司基本情况 | | | | | | | 公司股票简况 | | | | | | | 股票种类 股票上市交易所 股票简称 | | | 股票代码 | | 变更前股票 | | 简称 | | | | | | | A股 上海证券交易所 振德医疗 | | | 603301 | - | | | 联系人和联 ...

Core Viewpoint - The company, ZhenDe Medical Supplies Co., Ltd., is set to hold an investor briefing on September 11, 2025, to discuss its 2025 semi-annual performance and financial results, following the release of its semi-annual report on August 28, 2025 [1][2]. Group 1: Meeting Details - The investor briefing will take place on September 11, 2025, from 10:00 AM to 11:00 AM at the Shanghai Stock Exchange Roadshow Center [2]. - The meeting will be conducted in an interactive online format, allowing for real-time communication between the company and investors [1][2]. - Participants will include the company's chairman and general manager, financial officer, board secretary, and independent directors, with potential adjustments based on special circumstances [2]. Group 2: Investor Participation - Investors can join the briefing by logging into the Shanghai Stock Exchange Roadshow Center website during the scheduled time [2]. - Prior to the meeting, investors can submit questions from September 4 to September 10, 2025, by accessing the "Question Pre-collection" section on the website or through provided contact methods [2][3]. - The company will address commonly asked questions during the briefing [1][2]. Group 3: Contact Information - Contact persons for inquiries are Ji Baohai and Yu Ping, with a provided phone number and email for further communication [3]. - Investors can view the meeting's outcomes and key content on the Shanghai Stock Exchange Roadshow Center website after the event [3].

振德医疗用品股份有限公司2025 年半年度报告 公司代码：603301 公司简称：振德医疗 振德医疗用品股份有限公司 2025 年半年度报告 1 / 162 振德医疗用品股份有限公司2025 年半年度报告 重要提示 一、 本公司董事会及董事、高级管理人员保证半年度报告内容的真实性、准确性、完整性，不 存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 公司全体董事出席董事会会议。 三、 本半年度报告未经审计。 四、 公司负责人鲁建国、主管会计工作负责人金海萍及会计机构负责人（会计主管人员）马淑 燕声明：保证半年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 公司2025年中期不进行利润分配或资本公积金转增股本。 六、 前瞻性陈述的风险声明 √适用 □不适用 本报告中所涉及的未来计划、发展战略等前瞻性描述不构成公司对投资者的实质承诺，请投 资者注意投资风险。 七、 是否存在被控股股东及其他关联方非经营性占用资金情况 否 八、 是否存在违反规定决策程序对外提供担保的情况 否 九、 是否存在半数以上董事无法保证公司所披露半年度报告的真实性、准 ...

证券代码：603301 证券简称：振德医疗 公告编号：2025-032 振德医疗用品股份有限公司 关于召开 2025 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 1、会议召开时间：2025 年 9 月 11 日（星期四）10:00-11:00 2、会议召开地点：上海证券交易所上证路演中心（网址： http://roadshow.sseinfo.com/） 3、会议召开方式：上证路演中心网络互动 4、投资者可于 2025 年 9 月 4 日（星期四）至 9 月 10 日（星期 三）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或 通过本公告后附的电话、传真和指定邮箱进行提问。公司将在说明会 上选择投资者普遍关注的问题进行回答。 振德医疗用品股份有限公司（以下简称"公司"）已于 2025 年 8 月 28 日发布公司 2025 年半年度报告。为便于广大投资者更全面深入 地了解公司 2025 年半年度经营成果、财务状况，公司计划于 2025 年 9 月 11 日上午 10: ...

振德医疗公告，2025年上半年营业收入21亿元，同比增长2.83%。净利润1.28亿元，同比下降20.70%。 公司2025年中期不进行利润分配或资本公积金转增股本。 ...

8月27日，振德医疗大宗交易成交10万股，成交额232万元，占当日总成交额的2.07%，成交价23.2元，较市场收盘价23.2元持平。 | 交易日期 | 证券简称 | 证券代码 | 成交价(元) 成交金额(万元) 成交量(*) 买入营业部 | | | | 卖出营业部 | | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-08-27 | 振德医疗 | 603301 | 23.2 | 232 10 | 国泰海通证券股份 | 东方证券股份有限 | | | | | | | | 有限公司上海长宁 | 公司芜湖北京中路 | | | | | | | | 区江苏路证券营业 | 证券营业部 | | ...